Mark G. Charest, Ph.D. is a founding partner of LifeSci Fund Management, LLC and a portfolio manager for the AlphaCentric LifeSci Healthcare Fund. He is an inventor on 8 drug patents and has more than a decade of healthcare investing experience at several specialized $1B+ AUM healthcare technology funds. Mark was a Kauffman Fellow at Panorama Capital where he served on the board of directors of Itero Biopharmaceuticals and was a board observer at Presidio Pharmaceuticals and PowerVision. Prior to his investment career, Mark held an operating role in the oncology area as a Medicinal Chemistry Lab Manager at the Novartis Institutes for BioMedical Research. In this episode, Phil sits down with Mark to learn more about biotech investing, drug pricing, the FDA approval process, and what's being valued in the marketplace.